Endocrinologic Sequelae of Anorexia Nervosa and Obesity

[1]  R. Eastell,et al.  Free 25-hydroxyvitamin D is low in obesity, but there are no adverse associations with bone health. , 2016, The American journal of clinical nutrition.

[2]  Hang Lee,et al.  Effect of Chronic Athletic Activity on Brown Fat in Young Women , 2016, PloS one.

[3]  M. Horlick,et al.  Weight Loss and Health Status 3 Years after Bariatric Surgery in Adolescents. , 2016, The New England journal of medicine.

[4]  B. Pyrżak,et al.  Thyroid Function in Obese Children and Adolescents and Its Association with Anthropometric and Metabolic Parameters. , 2016, Advances in experimental medicine and biology.

[5]  Hunna J. Watson,et al.  Clinical presentation of eating disorders in young males at a tertiary setting , 2015, Journal of eating disorders.

[6]  C. Gordon,et al.  Skeletal complications of eating disorders. , 2015, Metabolism: clinical and experimental.

[7]  Kevin D Hall,et al.  Validation of an inexpensive and accurate mathematical method to measure long-term changes in free-living energy intake. , 2015, The American journal of clinical nutrition.

[8]  A. Tomova,et al.  Influence of the body weight on the onset and progression of puberty in boys , 2015, Journal of pediatric endocrinology & metabolism : JPEM.

[9]  S. Sangiao-Alvarellos,et al.  Effect of Oral Glucose Administration on Rebound Growth Hormone Release in Normal and Obese Women: The Role of Adiposity, Insulin Sensitivity and Ghrelin , 2015, PloS one.

[10]  M. Lewitt,et al.  The Insulin-Like Growth Factor System in Obesity, Insulin Resistance and Type 2 Diabetes Mellitus , 2014, Journal of clinical medicine.

[11]  Maren R. Laughlin,et al.  Brown fat in humans: consensus points and experimental guidelines. , 2014, Cell metabolism.

[12]  E. Blood,et al.  Percentage body fat by dual-energy X-ray absorptiometry is associated with menstrual recovery in adolescents with anorexia nervosa. , 2014, Journal of Adolescent Health.

[13]  R. Weinstock,et al.  Youth-onset type 2 diabetes mellitus: lessons learned from the TODAY study. , 2014, Mayo Clinic proceedings.

[14]  R. Norman,et al.  Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society. , 2014, Human reproduction update.

[15]  F. de Jong,et al.  Differentiating between Cushing's disease and pseudo-Cushing's syndrome: comparison of four tests. , 2014, European journal of endocrinology.

[16]  Arne Ljungqvist,et al.  The IOC consensus statement: beyond the Female Athlete Triad—Relative Energy Deficiency in Sport (RED-S) , 2014, British Journal of Sports Medicine.

[17]  K. Flegal,et al.  Prevalence of childhood and adult obesity in the United States, 2011-2012. , 2014, JAMA.

[18]  T. Beck,et al.  Does Hormone Replacement Normalize Bone Geometry in Adolescents With Anorexia Nervosa? , 2014, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[19]  A. Klibanski,et al.  Anorexia nervosa, obesity and bone metabolism. , 2013, Pediatric endocrinology reviews : PER.

[20]  G. Johannsson,et al.  The GH/IGF-1 axis in obesity: pathophysiology and therapeutic considerations , 2013, Nature Reviews Endocrinology.

[21]  C. Kahn,et al.  Insulin and IGF-I inhibit GH synthesis and release in vitro and in vivo by separate mechanisms. , 2013, Endocrinology.

[22]  R. Shiffman,et al.  Management of Newly Diagnosed Type 2 Diabetes Mellitus (T2DM) in Children and Adolescents , 2013, Pediatrics.

[23]  C. Rosen,et al.  New insights into osteoporosis: the bone–fat connection , 2012, Journal of internal medicine.

[24]  C. Gordon,et al.  The effect of gonadal and adrenal steroid therapy on skeletal health in adolescents and young women with anorexia nervosa. , 2012, Metabolism: clinical and experimental.

[25]  H. Hoek,et al.  Epidemiology of Eating Disorders: Incidence, Prevalence and Mortality Rates , 2012, Current Psychiatry Reports.

[26]  M. Goldstein,et al.  Physiologic estrogen replacement increases bone density in adolescent girls with anorexia nervosa , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[27]  Mary T. Brinkoetter,et al.  Long-term metreleptin treatment increases bone mineral density and content at the lumbar spine of lean hypoleptinemic women. , 2011, Metabolism: Clinical and Experimental.

[28]  A. Breggia,et al.  Determinants of bone mineral density in obese premenopausal women. , 2011, Bone.

[29]  J. Horowitz,et al.  Rapid suppression of growth hormone concentration by overeating: potential mediation by hyperinsulinemia. , 2011, The Journal of clinical endocrinology and metabolism.

[30]  R. Lewis,et al.  Bone and fat relationships in postadolescent black females: a pQCT study , 2011, Osteoporosis International.

[31]  A. Klibanski,et al.  Effects of recombinant human growth hormone in anorexia nervosa: a randomized, placebo-controlled study. , 2010, The Journal of clinical endocrinology and metabolism.

[32]  M. Misra,et al.  Influence of ghrelin and adipocytokines on bone mineral density in adolescent female athletes with amenorrhea and eumenorrheic athletes. , 2010, Medicine and sport science.

[33]  Christopher R McCartney,et al.  Obesity and the pubertal transition in girls and boys. , 2010, Reproduction.

[34]  C. Gordon,et al.  Clinical practice. Functional hypothalamic amenorrhea. , 2010, The New England journal of medicine.

[35]  N. Sudo,et al.  Predictors of menstrual resumption by patients with anorexia nervosa , 2010, Eating and weight disorders : EWD.

[36]  B. Estour,et al.  Hormonal profile heterogeneity and short-term physical risk in restrictive anorexia nervosa. , 2010, The Journal of clinical endocrinology and metabolism.

[37]  M. Górska,et al.  Insulin sensitivity, metabolic flexibility, and serum adiponectin concentration in women with anorexia nervosa. , 2010, Metabolism: clinical and experimental.

[38]  Hang Lee,et al.  Visceral fat is a negative predictor of bone density measures in obese adolescent girls. , 2010, The Journal of clinical endocrinology and metabolism.

[39]  C. Gordon,et al.  Bone Marrow Changes in Adolescent Girls With Anorexia Nervosa , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[40]  A. Klibanski,et al.  Neuroendocrine consequences of anorexia nervosa in adolescents. , 2010, Endocrine development.

[41]  L. Caregaro,et al.  Time trends in age at onset of anorexia nervosa and bulimia nervosa. , 2009, The Journal of clinical psychiatry.

[42]  L. Levitsky,et al.  Effect of body mass index on peak growth hormone response to provocative testing in children with short stature. , 2009, The Journal of clinical endocrinology and metabolism.

[43]  M. Goldstein,et al.  Effects of rhIGF-1 administration on surrogate markers of bone turnover in adolescents with anorexia nervosa. , 2009, Bone.

[44]  C. Rosen,et al.  Fat targets for skeletal health , 2009, Nature Reviews Rheumatology.

[45]  M. Bredella,et al.  Increased bone marrow fat in anorexia nervosa. , 2009, The Journal of clinical endocrinology and metabolism.

[46]  S. M. You,et al.  The effects of central adiposity on growth hormone (GH) response to GH-releasing hormone-arginine stimulation testing in men. , 2008, The Journal of clinical endocrinology and metabolism.

[47]  G. Hewitt,et al.  Assessment and management of bone health in adolescents with anorexia nervosa. Part two: bone health in adolescents with anorexia nervosa. , 2008, Journal of pediatric and adolescent gynecology.

[48]  M. Bredella,et al.  Lower growth hormone and higher cortisol are associated with greater visceral adiposity, intramyocellular lipids, and insulin resistance in overweight girls. , 2008, American journal of physiology. Endocrinology and metabolism.

[49]  L. Hemphill,et al.  Growth hormone deficiency by growth hormone releasing hormone-arginine testing criteria predicts increased cardiovascular risk markers in normal young overweight and obese women. , 2008, The Journal of clinical endocrinology and metabolism.

[50]  N. Golden,et al.  The Pathophysiology of Amenorrhea in the Adolescent , 2008, Annals of the New York Academy of Sciences.

[51]  V. Montori,et al.  The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. , 2008, The Journal of clinical endocrinology and metabolism.

[52]  P. Kaplowitz.  Link Between Body Fat and the Timing of Puberty , 2008, Pediatrics.

[53]  V. Basevi.  Standards of medical care in diabetes--2007. , 2009, Diabetes care.

[54]  L. Caregaro,et al.  Association between low height and eating disorders: cause or effect? , 2007, The International journal of eating disorders.

[55]  N. Kaciroti,et al.  Erratum: Weight status in young girls and the onset of puberty (Pediatrics (March 2001) 119, (e624-e630) DOI: 10.1542/peds.2006-2186) , 2007 .

[56]  J. Shaw,et al.  The metabolic syndrome in children and adolescents , 2007, The Lancet.

[57]  M. Goldstein,et al.  Relationships between serum adipokines, insulin levels, and bone density in girls with anorexia nervosa. , 2007, The Journal of clinical endocrinology and metabolism.

[58]  D. Stein,et al.  Modulation of adiponectin and leptin during refeeding of female anorexia nervosa patients. , 2007, The Journal of clinical endocrinology and metabolism.

[59]  J. Monson,et al.  Modulation of glucocorticoid metabolism by the growth hormone – IGF‐1 axis , 2007, Clinical endocrinology.

[60]  A. Klibanski,et al.  Androgens in women with anorexia nervosa and normal-weight women with hypothalamic amenorrhea. , 2007, The Journal of clinical endocrinology and metabolism.

[61]  Joyce M. Lee,et al.  Weight Status in Young Girls and the Onset of Puberty , 2007, Pediatrics.

[62]  J. Glowacki,et al.  DHEA and the skeleton (through the ages) , 1999, Endocrine.

[63]  S. Ferris,et al.  GH peak response to GHRH-arginine: relationship to insulin resistance and other cardiovascular risk factors in a population of adults aged 50–90 , 2006, Clinical endocrinology.

[64]  K. Gauvreau,et al.  Inflammation and changes in metabolic syndrome abnormalities in US adolescents: findings from the 1988-1994 and 1999-2000 National Health and Nutrition Examination Surveys. , 2006, Clinical chemistry.

[65]  J. Shaw,et al.  Metabolic syndrome—a new world‐wide definition. A Consensus Statement from the International Diabetes Federation , 2006, Diabetic medicine : a journal of the British Diabetic Association.

[66]  A. Klibanski,et al.  Elevated peptide YY levels in adolescent girls with anorexia nervosa. , 2006, The Journal of clinical endocrinology and metabolism.

[67]  R. Krauss,et al.  Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement , 2005, Current opinion in cardiology.

[68]  Mary L Bouxsein,et al.  Mechanisms of Disease: is osteoporosis the obesity of bone? , 2006, Nature Clinical Practice Rheumatology.

[69]  C. Lebrun,et al.  Effect of oral contraceptives and hormone replacement therapy on bone mineral density in premenopausal and perimenopausal women: a systematic review , 2005, British Journal of Sports Medicine.

[70]  Sheila M. Williams,et al.  Bone and Body Composition of Children and Adolescents With Repeated Forearm Fractures , 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[71]  M. Boldrin,et al.  Effect of orlistat on weight and body composition in obese adolescents: a randomized controlled trial. , 2005, JAMA.

[72]  S. Bloom,et al.  Ghrelin, peptide YY, glucose-dependent insulinotropic polypeptide, and hunger responses to a mixed meal in anorexic, obese, and control female adolescents. , 2005, The Journal of clinical endocrinology and metabolism.

[73]  M. Jacobson,et al.  Alendronate for the treatment of osteopenia in anorexia nervosa: a randomized, double-blind, placebo-controlled trial. , 2005, The Journal of clinical endocrinology and metabolism.

[74]  J. Chan,et al.  Recombinant human leptin in women with hypothalamic amenorrhea. , 2004, The New England journal of medicine.

[75]  A. Klibanski,et al.  Effects of risedronate on bone density in anorexia nervosa. , 2004, The Journal of clinical endocrinology and metabolism.

[76]  Tetsuya Tagami,et al.  Adiponectin in anorexia nervosa and bulimia nervosa. , 2004, The Journal of clinical endocrinology and metabolism.

[77]  A. Klibanski,et al.  Alterations in cortisol secretory dynamics in adolescent girls with anorexia nervosa and effects on bone metabolism. , 2003, The Journal of clinical endocrinology and metabolism.

[78]  J. Argente,et al.  Ghrelin levels in obesity and anorexia nervosa: effect of weight reduction or recuperation. , 2004, The Journal of pediatrics.

[79]  J. Chan,et al.  The role of falling leptin levels in the neuroendocrine and metabolic adaptation to short-term starvation in healthy men. , 2003, The Journal of clinical investigation.

[80]  Tim Cheetham,et al.  Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. , 2003, The New England journal of medicine.

[81]  U. Bailer,et al.  A review of neuropeptide and neuroendocrine dysregulation in anorexia and bulimia nervosa. , 2003, Current drug targets. CNS and neurological disorders.

[82]  R. Dardennes,et al.  Balance in ghrelin and leptin plasma levels in anorexia nervosa patients and constitutionally thin women. , 2003, The Journal of clinical endocrinology and metabolism.

[83]  Graham M Lord,et al.  Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. , 2002, The Journal of clinical investigation.

[84]  S. Emans,et al.  Physiologic regulators of bone turnover in young women with anorexia nervosa. , 2002, The Journal of pediatrics.

[85]  A. Klibanski,et al.  Effects of recombinant human IGF-I and oral contraceptive administration on bone density in anorexia nervosa. , 2002, The Journal of clinical endocrinology and metabolism.

[86]  M. Jacobson,et al.  The effect of estrogen-progestin treatment on bone mineral density in anorexia nervosa. , 2002, Journal of pediatric and adolescent gynecology.

[87]  Mario Maj,et al.  Plasma Levels of Neuroactive Steroids Are Increased in Untreated Women With Anorexia Nervosa or Bulimia Nervosa , 2001, Psychosomatic medicine.

[88]  C. Mantzoros,et al.  Endocrinologic and psychological effects of short-term dexamethasone in anorexia nervosa. , 2000, Eating and weight disorders : EWD.

[89]  G. Wyshak,et al.  Teenaged girls, carbonated beverage consumption, and bone fractures. , 2000, Archives of pediatrics & adolescent medicine.

[90]  E. Goodman,et al.  Changes in Bone Turnover Markers and Menstrual Function After Short‐term Oral DHEA in Young Women with Anorexia Nervosa , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[91]  J. Treasure,et al.  Dissociation of Bone Turnover in Anorexia Nervosa , 1998, Annals of clinical biochemistry.

[92]  C. Mantzoros,et al.  Leptin in relation to resumption of menses in women with anorexia nervosa , 1998, Molecular Psychiatry.

[93]  S. O’Rahilly,et al.  A frameshift mutation in MC4R associated with dominantly inherited human obesity , 1998, Nature Genetics.

[94]  M. Hotta,et al.  The importance of body weight history in the occurrence and recovery of osteoporosis in patients with anorexia nervosa: evaluation by dual X-ray absorptiometry and bone metabolic markers. , 1998, European journal of endocrinology.

[95]  P. Zimmet,et al.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation , 1998, Diabetic medicine : a journal of the British Diabetic Association.

[96]  L. Ibáñez,et al.  Insulin Resistance, Premature Adrenarche, and a Risk of the Polycystic Ovary Syndrome (PCOS) , 1998, Trends in Endocrinology & Metabolism.

[97]  A. Klibanski,et al.  Effects of short-term recombinant human insulin-like growth factor I administration on bone turnover in osteopenic women with anorexia nervosa. , 1996, The Journal of clinical endocrinology and metabolism.

[98]  L. Vignati,et al.  Serum leptin levels in women with anorexia nervosa. , 1996, The Journal of clinical endocrinology and metabolism.

[99]  C. Mantzoros,et al.  Role of leptin in the neuroendocrine response to fasting , 1996, Nature.

[100]  Hongping,et al.  Leptin is a metabolic signal to the reproductive system. , 1996, Endocrinology.

[101]  Philip W. Gold,et al.  The hypothalamic-pituitary-adrenal axis in anorexia nervosa , 1996, Psychiatry Research.

[102]  F. Casanueva,et al.  Impaired growth hormone secretion in obese subjects is partially reversed by acipimox-mediated plasma free fatty acid depression. , 1996, The Journal of clinical endocrinology and metabolism.

[103]  S. Grottoli,et al.  In obesity the somatotrope response to either growth hormone-releasing hormone or arginine is inhibited by somatostatin or pirenzepine but not by glucose. , 1995, The Journal of clinical endocrinology and metabolism.

[104]  H. Orskov,et al.  Free insulin-like growth factors in human obesity. , 1995, Metabolism: clinical and experimental.

[105]  K. Main,et al.  Massive weight loss restores 24-hour growth hormone release profiles and serum insulin-like growth factor-I levels in obese subjects , 1995 .

[106]  D. Schoenfeld,et al.  The effects of estrogen administration on trabecular bone loss in young women with anorexia nervosa. , 1995, The Journal of clinical endocrinology and metabolism.

[107]  G. Komaki,et al.  Insulin response to intravenous glucose in patients with anorexia nervosa showing low insulin response to oral glucose. , 1994, The Journal of clinical endocrinology and metabolism.

[108]  R. Kreipe,et al.  Menstruation and fertility following anorexia nervosa , 1994 .

[109]  R. Frisch,et al.  Carbonated beverages, dietary calcium, the dietary calcium/phosphorus ratio, and bone fractures in girls and boys. , 1994, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

[110]  T. Groth,et al.  Analysis of 24-hour growth hormone profiles in healthy boys and girls of normal stature: relation to puberty. , 1994, The Journal of clinical endocrinology and metabolism.

[111]  R. Rizzoli,et al.  Longitudinal monitoring of bone mass accumulation in healthy adolescents: evidence for a marked reduction after 16 years of age at the levels of lumbar spine and femoral neck in female subjects. , 1992, The Journal of clinical endocrinology and metabolism.

[112]  W. Goodman,et al.  Changes in vertebral bone density in black girls and white girls during childhood and puberty. , 1991, The New England journal of medicine.

[113]  J D Veldhuis,et al.  Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men. , 1991, The Journal of clinical endocrinology and metabolism.

[114]  R. Rizzoli,et al.  Critical years and stages of puberty for spinal and femoral bone mass accumulation during adolescence. , 1991, The Journal of clinical endocrinology and metabolism.

[115]  W. O'Fallon,et al.  50-year trends in the incidence of anorexia nervosa in Rochester, Minn.: a population-based study. , 1991, The American journal of psychiatry.

[116]  B. Davies,et al.  The Dexamethasone Suppression Test in Anorexia Nervosa the Influence of Weight, Depression, Adrenocorticotrophic Hormone and Dexamethasone , 1990, British Journal of Psychiatry.

[117]  I. Litt,et al.  Decreased bone density in adolescent girls with anorexia nervosa. , 1990, Pediatrics.

[118]  M. Demitrack,et al.  CSF oxytocin in anorexia nervosa and bulimia nervosa: clinical and pathophysiologic considerations. , 1990, The American journal of psychiatry.

[119]  B. Estour,et al.  RAPID ESCAPE OF CORTISOL FROM SUPPRESSION IN RESPONSE TO I. V. DEXAMETHASONE IN ANOREXIA NERVOSA * , 1990, Clinical endocrinology.

[120]  C. Kuhn,et al.  Abnormalities in the response of plasma arginine vasopressin during hypertonic saline infusion in patients with eating disorders , 1989, Biological Psychiatry.

[121]  J. Witschi,et al.  Nonalcoholic carbonated beverage consumption and bone fractures among women former college athletes , 1989, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[122]  G. Reaven.  Role of Insulin Resistance in Human Disease , 1988, Diabetes.

[123]  K. Halmi,et al.  The endocrinology of anorexia nervosa and bulimia nervosa. , 1988, Endocrinology and metabolism clinics of North America.

[124]  F. Casanueva,et al.  Adrenal Androgen Secretion and Dopaminergic Activity in Anorexia Nervosa , 1988, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[125]  B. Timothy Walsh,et al.  Hypothalamic-pituitary-adrenal-cortical activity in anorexia nervosa and bulimia , 1987, Psychoneuroendocrinology.

[126]  P. Jouannet,et al.  ANOMALOUS PROTEIN COMPLEMENT OF SPERM NUCLEI IN SOME INFERTILE MEN , 1987, The Lancet.

[127]  A. Schally,et al.  Free fatty acids block growth hormone (GH) releasing hormone-stimulated GH secretion in man directly at the pituitary. , 1987, The Journal of clinical endocrinology and metabolism.

[128]  B. Zinman,et al.  Changes in insulin sensitivity and clearance in anorexia nervosa. , 1986, Metabolism: clinical and experimental.

[129]  M. Pertschuk,et al.  Osteoporosis and hip fracture in a young woman with anorexia nervosa. , 1986, Clinical orthopaedics and related research.

[130]  G. Chrousos,et al.  Abnormal hypothalamic-pituitary-adrenal function in anorexia nervosa. Pathophysiologic mechanisms in underweight and weight-corrected patients. , 1986, The New England journal of medicine.

[131]  N. Ling,et al.  The responses of plasma adrenocorticotropin and cortisol to corticotropin-releasing hormone (CRH) and cerebrospinal fluid immunoreactive CRH in anorexia nervosa patients. , 1986, The Journal of clinical endocrinology and metabolism.

[132]  A. Scheen,et al.  Insulin-stimulated glucose disposal is not increased in anorexia nervosa. , 1985, The Journal of clinical endocrinology and metabolism.

[133]  I. Mills,et al.  Concentration patterns of plasma dehydroepiandrosterone, delta 5-androstenediol and their sulphates, testosterone and cortisol in normal healthy women and in women with anorexia nervosa. , 1985, Acta endocrinologica.

[134]  R M Neer,et al.  Osteoporosis in women with anorexia nervosa. , 1984, The New England journal of medicine.

[135]  C. Demangeat,et al.  The Role of Insulin, Glucagon and Growth Hormone in the Regulation of Plasma Glucose and Free Fatty Acid Levels in Anorexia Nervosa , 1984, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[136]  L. Lanyon,et al.  Regulation of bone formation by applied dynamic loads. , 1984, The Journal of bone and joint surgery. American volume.

[137]  J Levin,et al.  Subnormal plasma dehydroisoandrosterone to cortisol ratio in anorexia nervosa: a second hormonal parameter of ontogenic regression. , 1983, The Journal of clinical endocrinology and metabolism.

[138]  K. Halmi,et al.  Amenorrhea in anorexia nervosa: examination of the critical body weight hypothesis. , 1982, Biological psychiatry.

[139]  K. Pirke,et al.  Relationship between weight gain and hypothalamic pituitary adrenal function in patients with anorexia nervosa. , 1980, Journal of steroid biochemistry.

[140]  A Wakeling,et al.  Amenorrhoea, body weight and serum hormone concentrations, with particular reference to prolactin and thyroid hormones in anorexia nervosa , 1979, Psychological Medicine.

[141]  J. Katz,et al.  Weight and Circadian Luteinizing Hormone Secretory Pattern in Anorexia Nervosa , 1978, Psychosomatic medicine.

[142]  R. Bayliss,et al.  Hypothalamo-pituitary-thyroid function in anorexia nervosa: influence of weight gain. , 1978, British medical journal.

[143]  H. Moldofsky,et al.  Hypothalamic Function as Related to Body Weight and Body Fat in Anorexia Nervosa , 1978, Psychosomatic medicine.

[144]  U. Knuth,et al.  AMENORRHOEA AND LOSS OF WEIGHT , 1977, British journal of obstetrics and gynaecology.

[145]  H. Gharib,et al.  Hypothalamic-endocrine dysfunction in anorexia nervosa. , 1977, Mayo Clinic proceedings.

[146]  H. Roffwarg,et al.  Cortisol secretion and metabolism in anorexia nervosa. , 1977, The New England journal of medicine.

[147]  E. Wynder,et al.  DIET AND PROLACTIN RELEASE , 1976, The Lancet.

[148]  R. Vigersky,et al.  Delayed pituitary hormone response to LRF and TRF in patients with anorexia nervosa and with secondary amenorrhea associated with simple weight loss. , 1976, The Journal of clinical endocrinology and metabolism.

[149]  C. Wollheim,et al.  Plasma Growth Hormone, Insulin, and Glucagon Responses to Arginine Infusion in Children and Adolescents with Idiopathic Short Stature, Isolated Growth Hormone Deficiency, Panhypopituitarism, and Anorexia Nervosa , 1975, Pediatric Research.

[150]  H. Moldofsky,et al.  Hypothalamic-pituitary function in anorexia nervosa. , 1975, Archives of general psychiatry.

[151]  J. Parks,et al.  Low serum triiodothyronine in patients with anorexia nervosa. , 1975, The Journal of clinical endocrinology and metabolism.

[152]  S. Kapen,et al.  Anorexia nervosa. Immaturity of the 24-hour luteinizing hormone secretory pattern. , 1974, The New England journal of medicine.

[153]  R. Frisch,et al.  Menstrual Cycles: Fatness as a Determinant of Minimum Weight for Height Necessary for Their Maintenance or Onset , 1974, Science.

[154]  M. Lipsett,et al.  Hypothalamic dysfunction in patients with anorexia nervosa. , 1974, Medicine.

[155]  H. Bruch.  Thin fat people. , 1973, Journal of the American Medical Women's Association.

[156]  V. Wynn,et al.  The plasma sugar, free fatty acid, cortisol, and growth hormone response to insulin, and the comparison of this procedure with other tests of pituitary and adrenal function. II. In patients with hypothalamic or pituitary dysfunction or anorexia nervosa. , 1966, The Journal of clinical investigation.